Britta C. Martel
Leo Pharma (Denmark)(DK)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research
Most-Cited Works
- Translational Animal Models of Atopic Dermatitis for Preclinical Studies.(2017)
- → Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis(2016)72 cited
- → Hypochlorous acid is antipruritic and anti‐inflammatory in a mouse model of atopic dermatitis(2017)68 cited
- → Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years(2024)46 cited
- → The immunoglobulin superfamily member CD200R identifies cells involved in type 2 immune responses(2017)33 cited
- → Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment(2025)9 cited
- → Different cytokine profiles of skin-derived T cell cultures from patients with atopic dermatitis and psoriasis(2015)8 cited
- → Imiquimod induces skin inflammation in humanized BRGSF mice with limited human immune cell activity(2023)3 cited
- → Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results(2025)2 cited
- → Human Atopic Dermatitis Skin‐derived T Cells can Induce a Reaction in Mouse Keratinocytes in vivo(2015)2 cited